Susquehanna International Group’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-198,375
| Closed | -$1.9M | – | 7329 |
|
|
2024
Q4 | $1.9M | Buy |
+198,375
| New | +$1.9M | ﹤0.01% | 2047 |
|
|
2024
Q3 | – | Sell |
-16,006
| Closed | -$46.7K | – | 6748 |
|
|
2024
Q2 | $46.7K | Sell |
16,006
-17,837
| -53% | -$52.1K | ﹤0.01% | 5288 |
|
|
2024
Q1 | $108K | Sell |
33,843
-21,081
| -38% | -$67.2K | ﹤0.01% | 4981 |
|
|
2023
Q4 | $185K | Buy |
54,924
+28,834
| +111% | +$96.9K | ﹤0.01% | 5048 |
|
|
2023
Q3 | $62.1K | Sell |
26,090
-15,280
| -37% | -$36.4K | ﹤0.01% | 5060 |
|
|
2023
Q2 | $72.8K | Sell |
41,370
-610,024
| -94% | -$1.07M | ﹤0.01% | 5113 |
|
|
2023
Q1 | $2.01M | Buy |
651,394
+403,618
| +163% | +$1.24M | ﹤0.01% | 1968 |
|
|
2022
Q4 | $1.31M | Buy |
247,776
+83,675
| +51% | +$443K | ﹤0.01% | 2029 |
|
|
2022
Q3 | $579K | Buy |
+164,101
| New | +$579K | ﹤0.01% | 3329 |
|
|
2022
Q1 | – | Sell |
-16,863
| Closed | -$115K | – | 6670 |
|
|
2021
Q4 | $115K | Buy |
+16,863
| New | +$115K | ﹤0.01% | 5241 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6225 |
|
|
2021
Q2 | – | Sell |
-48,451
| Closed | -$463K | – | 6038 |
|
|
2021
Q1 | $463K | Buy |
+48,451
| New | +$463K | ﹤0.01% | 3933 |
|